Rodés, Juan

Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis

Fernández, J., Navasa, M., Gómez, J., Colmenero, J., Vila, J., Arroyo, V., & Rodés, J. (2002) · Hepatology

Liver Disease and TransplantationNosocomial Infections in ICU

Cited by 954

Excellent Long-Term Survival in Patients With Primary Biliary Cirrhosis and Biochemical Response to Ursodeoxycholic Acid

Parés, A., Caballería, L., & Rodés, J. (2006) · Gastroenterology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 756

Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis

Guañabens, N., Parés, A., Ros, I., Caballería, L., Pons, F., Vidal, S., Monegal, A., Peris, P., & Rodés, J. (2005) · Journal of Hepatology

Liver Diseases and ImmunityBone health and osteoporosis research

Cited by 179

Alendronate Is More Effective Than Etidronate for Increasing Bone Mass in Osteopenic Patients With Primary Biliary Cirrhosis

Guañabens, N., Parés, A., Ros, I., Alvarez, L., Pons, F., Caballería, L., Monegal, A., de Osaba, J. M. M., Roca, M., Peris, P., et al. (2003) · American Journal of Gastroenterology

Bone health and osteoporosis researchLiver Diseases and Immunity

Cited by 119

Role of a research ethics committee in follow-up and publication of results

Pich, J., Carné, X., Arnaiz, J.-A., Gómez, B., Trilla, A., & Rodés, J. (2003) · The Lancet

Ethics in Clinical ResearchPharmaceutical industry and healthcare

Cited by 104

Natural history of primary biliary cirrhosis

Parés, A., & Rodés, J. (2003) · Clinics in Liver Disease

Liver Diseases and ImmunityLiver Disease and Transplantation

Cited by 89